X-chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain

Human Molecular Genetics

Volumn 13, Issue 12, 2004, Pages 1275-1286

  Braunschweig, Daniel ^a   Simcox, Thomas ^a   Samaco, Rodney C ^a   LaSalle, Janine M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; MUTANT PROTEIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; CYTOMETRY; FEMALE; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY; MALE; MOSAICISM; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETT SYNDROME; WILD TYPE; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKAGE;

ANIMALS; BRAIN; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; DOSAGE COMPENSATION, GENETIC; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HETEROZYGOTE; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; MODELS, ANIMAL; MOSAICISM; MUTATION; REPRESSOR PROTEINS; RETT SYNDROME; X CHROMOSOME;

EID: 3042775154     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh142     Document Type: Article

References (34)

1. Vanden Veyver, I.B. and Zoghbi, H.Y. (2000) Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr. Opin. Genet. Dev., 10, 275-279.
2. Shahbazian, M.D. and Zoghbi, H.Y. (2002) Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am. J. Hum. Genet., 71, 1259-1272.
3. Armstrong, D.D. (1997) Review of Rett syndrome. J. Neuropathol. Exp. Neurol., 56, 843-849.
4. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185-188.
5. Coy, J.F., Sedlacek, Z., Bachner, D., Delius, H. and Poustka, A. (1999) A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3′-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum. Mol. Genet., 8, 1253-1262.
6. D'Esposito, M., Quaderi, N.A., Ciccodicola, A., Bruni, P., Esposito, T., D'Urso, M. and Brown, S.D. (1996) Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm. Genome, 7, 533-535.
7. Reichwald, K., Thiesen, J., Wiehe, T., Weitzel, J., Poustka, W.A., Rosenthal, A., Platzer, M., Stratling, W.H. and Kioschis, P. (2000) Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. Mamm. Genome, 11, 182-190.
8. LaSalle, J., Goldstine, J., Balmer, D. and Greco, C. (2001) Quantitative localization of heterologous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum. Mol. Genet., 10, 1729-1740.
9. Shahbazian, M.D., Antalffy, B., Armstrong, D.L. and Zoghbi, H.Y. (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet., 11, 115-124.
10. Balmer, D., Goldstine, J., Rao, Y.M. and LaSalle, J.M. (2003) Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J. Mol. Med., 81, 61-68.
11. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F. and Bird, A. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69, 905-914.
12. Nan, X., Tate, P., Li, E. and Bird, A. (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol., 16, 414-421.
13. Nan, X., Campoy, F.J. and Bird, A. (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88, 471-481.
14. Chen, R.Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327-331.
15. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. and Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
16. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R. and Zoghbi, H. (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron, 35, 243-254.
17. Cohen, D.R., Matarazzo, V., Palmer, A.M., Tu, Y., Jeon, O.H., Pevsner, J. and Ronnett, G.V. (2003) Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol. Cell. Neurosci., 22, 417-429.
18. Akbarian, S., Chen, R.Z., Gribnau, J., Rasmussen, T.P., Fong, H., Jaenisch, R. and Jones, E.G. (2001) Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol. Dis., 8, 784-791.
19. Jung, B.P., Jugloff, D.G., Zhang, G., Logan, R., Brown, S. and Eubanks, J.H. (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J. Neurobiol., 55, 86-96.
20. Mullaney, B.C., Johnston, M.V. and Blue, M.E. (2004) Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience, 123, 939-949.
21. Zoghbi, H.Y., Percy, A.K., Schultz, R.J. and Fill, C. (1990) Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev., 12, 131-135.
22. Amir, R.E., Van den Veyver, I.B., Schultz, R., Malicki, D.M., Tran, C.Q., Dahle, E.J., Philippi, A., Timar, L., Percy, A.K., Motil, K.J. et al. (2000) Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann. Neurol., 47, 670-679.
23. Shahbazian, M.D., Sun, Y. and Zoghbi, H.Y. (2002) Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am. J. Med. Genet., 111, 164-168.
24. Wan, M., Lee, S.S., Zhang, X., Houwink-Manville, I., Song, H.R., Amir, R.E., Budden, S., Naidu, S., Pereira, J.L., Lo, I.F. et al. (1999) Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am. J. Hum. Genet., 65, 1520-1529.
25. Young, J.I. and Zoghbi, H.Y. (2004) X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome. Am. J. Hum. Genet., 74, 511-520.
26. Kallioniemi, O.P., Wagner, U., Kononen, J. and Sauter, G. (2001) Tissue microarray technology for high-throughput molecular profiling of cancer. Hum. Mol. Genet., 10, 657-662.
27. Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., Jaenisch, R. and Greenberg, M.E. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science, 302, 885-889.
28. Hoffbuhr, K., Devaney, J.M., LaFleur, B., Sirianni, N., Scacheri, C., Giron, J., Schuette, J., Innis, J., Marino, M., Philippart, M. et al. (2001) MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology, 56, 1486-1495.
29. Cassel, S., Revel, M.O., Kelche, C. and Zwiller, J. (2004) Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study. Neurobiol. Dis., 15, 206-211.
30. Samaco, R.C., Nagarajan, R.P., Braunschweig, D. and LaSalle, J.M. (2004) Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum. Mol. Genet., 13, 629-639.
31. Kriaucionis, S. and Bird, A. (2004) The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucl. Acids Res. 32, 1818-1823.
32. Mnatzakanian, G.N., Lohi, H., Munteanu, I., Alfred, S.E., Yamada, T., MacLeod, P.J., Jones, J.R., Scherer, S.W., Schanen, N.C., Friez, M.J. et al. (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet., 36, 339-341.
33. Balmer, D., Arredondo, J., Samaco, R.C. and LaSalle, J.M. (2002) MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum. Genet., 110, 545-552.
34. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G. and Sun, Y.E. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science, 302, 890-893.